Skip to main content

Advertisement

Log in

Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT

  • Nuclear Medicine
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Methylprednisolone pulse therapy (MPT) was introduced to avoid life-threatening complications in patients with systemic lupus erythematosus (SLE) with brain manifestations; however, the efficacy of MPT in SLE patients with brain involvement is still uncertain and needs to be objectively evaluated. We enrolled 15 female SLE patients with neuropsychiatric manifestations in this study. All patients had normal brain MRI and abnormal brain HMPAO-SPECT findings. Follow-up HMPAO-SPECT studies were conducted 2 weeks after MPT. Serum levels of anticardiolipin antibodies (ACA) and anti-ribosomal P antibodies (anti-P) were measured before and after MPT. Before MPT, 7 patients were positive for ACA and 7 patients were positive for anti-P. After MPT, none of the 15 patients demonstrated positive serologic findings or neuropsychiatric manifestations. Based on the follow up brain HMPAO-SPECT images following MPT, 13 patients showed disappearance of the perfusion defects and 2 patients showed partial recovery of rCBF. Brain HMPAO-SPECT imaging is a logical and objective tool for measuring the effects of MPT in SLE patients with brain involvement by determining of changes in rCBF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bluestein HG (1987) Neuropsychiatric manifestations of systemic lupus erythematosus. N Engl J Med 317:309–311

    CAS  PubMed  Google Scholar 

  2. Kimberly RP (1992) Steroid use in systemic lupus erythematosus. In: Lahita RG (ed) Systemic lupus erythematosus. Churchill Livingstone, New York, pp 918–919

  3. Kao CH, Ho YJ, Lan JL, Changlai SP, Liao KK, Chieng PU (1999) Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain MRI findings. Arthritis Rheum 42:61–68

    CAS  PubMed  Google Scholar 

  4. Lin WY, Wang SJ, Yen TC, Lan JL (1997) Technetium-99m HMPAO brain SPECT in systemic erythematosus with CNS involvement. J Nucl Med 38:1112–1115

    CAS  PubMed  Google Scholar 

  5. You DL, Tzen KY, Kao PF, Tsai MF (1998) Quantitative cerebral perfusion SPECT in systemic lupus erythematosus with severe central nervous involvement before and after methylprednisolone pulse therapy. J Neuroimaging 8:55–57

    CAS  PubMed  Google Scholar 

  6. Huang JL, Yeh KW, You DL, Hsieh KH (1997) Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment. Pediatr Neurol 17:44–48

    Article  CAS  PubMed  Google Scholar 

  7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    PubMed  Google Scholar 

  8. Carbotte RM, Denburg SD, Denburg JA, Nahmias C, Garnett ES (1992) Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 55:1054–1059

    CAS  PubMed  Google Scholar 

  9. Sibbitt WL Jr, Brooks WM, Haseler LJ, Griffey RH, Frank LM, Hart BL, Sibbitt RR (1995) Spin-spin relaxation of brain tissues in systemic lupus erythematosus. Arthritis Rheum 38:810–818

    PubMed  Google Scholar 

  10. Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng PU (1999) The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 26:129–134

    CAS  PubMed  Google Scholar 

  11. Hughes RAC (1994) Pathogenesis of neurological involvement in SLE. Lancet 343:580–581

    Google Scholar 

  12. Hanly JG, Walsh NMG, Sangalang V (1992) Brain pathology in systemic lupus erythematosus. J Rheumatol 19:732–741

    CAS  PubMed  Google Scholar 

  13. Bruyn GAW (1995) Controversies in lupus: nervous system involvement. Ann Rheum Dis 54:159–167

    CAS  PubMed  Google Scholar 

  14. Dutton JJ, Burde RM, Klingele TG (1982) Autoimmune retrobulbic optic neuritis. Am J Opthalmol 94:1–4

    Google Scholar 

  15. Barile L, Lavalle C (1992) Transverse myelitis in systemic lupus erythematosus: the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 19:370–372

    CAS  PubMed  Google Scholar 

  16. Eyanson S, Passo MH, Aldo-Benson MA, Benson MD (1980) Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis 39:377–380

    CAS  PubMed  Google Scholar 

  17. Hellman RS, Tikofsky RS, Van Heertum R, Coade G, Carretta R, Hoffmann RG (1994) A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPECT technetium-99m exametazime (HMPAO). Eur J Nucl Med 21:306–313

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. S. Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, S.S., Huang, W.S., Chen, J.J.H. et al. Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT. Eur Radiol 14, 1311–1315 (2004). https://doi.org/10.1007/s00330-003-2166-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-003-2166-3

Keywords

Navigation